Evaluation of "Gastromiro" for bowel opacification during computed tomography: comparison with diatrizoate and barium sulphate.

@article{Doyle1993EvaluationO,
  title={Evaluation of "Gastromiro" for bowel opacification during computed tomography: comparison with diatrizoate and barium sulphate.},
  author={G. J. Doyle and Susan O'Donnell and Jay R. McDonald and Lakkur N. S. Murthy and Michael Keir and Andrew R. Wright},
  journal={The British journal of radiology},
  year={1993},
  volume={66 788},
  pages={681-4}
}
A new oral formulation of iopamidol, "Gastromiro", was evaluated as a bowel contrast agent during abdominal computed tomography (CT). Comparison was made with the well established agents sodium/meglumine diatrizoate ("Urografin 370") and dilute barium sulphate ("E-Z CAT") in a randomized, blind study of 150 consecutive patients undergoing abdominal and/or pelvic CT. Parameters assessed included quality of bowel opacification, artefact generation, contrast-medium palatibility, side effects and… CONTINUE READING